Periodontitis and diabetes: a two-way relationship
Tóm tắt
Từ khóa
Tài liệu tham khảo
Fox CH (1992) New considerations in the prevalence of periodontal disease. Curr Opin Dent 2:5–11
Fox CH, Jette AM, McGuire SM, Feldman HA, Douglass CW (1994) Periodontal disease among New England elders. J Periodontol 65:676–684
Kelly M, Steele J, Nuttall N et al (2000) The condition of supporting structures. In: Walker A, Cooper I (eds) Adult dental health survey: oral health in the United Kingdom 1998. The Stationery Office, London, pp 123–146
O'Dowd LK, Durham J, McCracken GI, Preshaw PM (2010) Patients' experiences of the impact of periodontal disease. J Clin Periodontol 37:334–339
Grossi SG, Genco RJ, Machtei EE et al (1995) Assessment of risk for periodontal disease. II. Risk indicators for alveolar bone loss. J Periodontol 66:23–29
Salvi GE, Carollo-Bittel B, Lang NP (2008) Effects of diabetes mellitus on periodontal and peri-implant conditions: update on associations and risks. J Clin Periodontol 35:398–409
Chavarry NGM, Vettore MV, Sansone C, Sheiham A (2009) The relationship between diabetes mellitus and destructive periodontal disease: a meta-analysis. Oral Health Prev Dent 7:107–127
Khader YS, Dauod AS, El-Qaderi SS, Alkafajei A, Batayha WQ (2006) Periodontal status of diabetics compared with nondiabetics: a meta-analysis. J Diabetes Complicat 20:59–68
Tsai C, Hayes C, Taylor GW (2002) Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Community Dent Oral Epidemiol 30:182–192
Nelson RG, Shlossman M, Budding LM et al (1990) Periodontal disease and NIDDM in Pima Indians. Diabetes Care 13:836–840
Taylor GW, Burt BA, Becker MP, Genco RJ, Shlossman M (1998) Glycemic control and alveolar bone loss progression in type 2 diabetes. Ann Periodontol 3:30–39
Emrich LJ, Shlossman M, Genco RJ (1991) Periodontal disease in non-insulin dependent diabetes mellitus. J Periodontol 62:123–131
Cianciola LJ, Park PH, Bruck E, Mosovich L, Genco RJ (1982) Prevalence of periodontal disease in insulin-dependent mellitus (juvenile diabetes). J Am Dent Assoc 104:653–660
Lalla E, Cheng B, Lal S et al (2007) Diabetes mellitus promotes periodontal destruction in children. J Clin Periodontol 34:294–298
Loe H (1993) Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care 16:329–334
American Diabetes Association Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 26:S5–S20
Perlstein MI, Bissada NF (1977) Influence of obesity and hypertension on the severity of periodontitis in rats. Oral Surg Oral Med Oral Pathol 43:707–719
Pischon N, Heng N, Bernimoulin JP, Kleber BM, Willich SN, Pischon T (2007) Obesity, inflammation, and periodontal disease. J Dent Res 86:400–409
Al-Zahrani MS, Bissada NF, Borawskit EA (2003) Obesity and periodontal disease in young, middle-aged, and older adults. J Periodontol 74:610–615
Genco RJ, Grossi SG, Ho A, Nishimura F, Murayama Y (2005) A proposed model linking inflammation to obesity, diabetes, and periodontal infections. J Periodontol 76:2075–2084
Chaffee BW, Weston SJ (2010) Association between chronic periodontal disease and obesity: a systematic review and meta-analysis. J Periodontol 81:1708–1724
Merchant AT, Pitiphat W, Rimm EB, Joshipura K (2003) Increased physical activity decreases periodontitis risk in men. Eur J Epidemiol 18:891–898
Al-Zahrani MS, Borawski EA, Bissada NF (2005) Increased physical activity reduces prevalence of periodontitis. J Dent 33:703–710
Taylor GW (2001) Bidirectional interrelationships between diabetes and periodontal diseases: an epidemiologic perspective. Ann Periodontol 6:99–112
Taylor GW, Burt BA, Becker MP et al (1996) Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol 67:1085–1093
Karjalainen KM, Knuuttila ML, von Dickhoff KJ (1994) Association of the severity of periodontal disease with organ complications in type 1 diabetic patients. J Periodontol 65:1067–1072
Moore PA, Weyant RJ, Mongelluzzo MB et al (1998) Type 1 diabetes mellitus and oral health: assessment of tooth loss and edentulism. J Public Health Dent 58:135–142
Moore PA, Weyant RJ, Mongelluzzo MB et al (1999) Type 1 diabetes mellitus and oral health: assessment of periodontal disease. J Periodontol 70:409–417
Thorstensson H, Kuylenstierna J, Hugoson A (1996) Medical status and complications in relation to periodontal disease experience in insulin-dependent diabetics. J Clin Periodontol 23:194–202
Shultis WA, Weil EJ, Looker HC et al (2007) Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes. Diabetes Care 30:306–311
Saremi A, Nelson RG, Tulloch-Reid M et al (2005) Periodontal disease and mortality in type 2 diabetes. Diabetes Care 28:27–32
The ADVANCE Collaborative Group (2001) Study rationale and design of ADVANCE: action in diabetes and vascular disease-preterax and diamicron MR controlled evaluation. Diabetologia 44:1118–1120
Li Q, Chalmers J, Czernichow S et al (2010) Oral disease and subsequent cardiovascular disease in people with type 2 diabetes: a prospective study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial. Diabetologia 53:2320–2327
Ide R, Hoshuyama T, Wilson D, Takahashi K, Higashi T (2011) Periodontal disease and incident diabetes: a seven-year study. J Dent Res 90:41–46
Demmer RT, Desvarieux M, Holtfreter B et al (2010) Periodontal status and A1C change: longitudinal results from the study of health in Pomerania (SHIP). Diabetes Care 33:1037–1043
Preshaw PM, Taylor JJ (2011) How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? J Clin Periodontol 38(suppl 11):60–84
Kinane DF, Preshaw PM, Loos BG (2011) Host-response: understanding the cellular and molecular mechanisms of host-microbial interactions—Consensus of the Seventh European Workshop on Periodontology. J Clin Periodontol 38(suppl 11):44–48
Dandona P, Aljada A, Bandyopadhyay A (2004) Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25:4–7
Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615–1625
Schmidt MI, Duncan BB, Sharrett AR et al (1999) Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 353:1649–1652
Nesto R (2004) C-reactive protein, its role in inflammation, type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones. Diabetic Med 21:810–817
Hotamisligil GS (2000) Molecular mechanisms of insulin resistance and the role of the adipocyte. Int J Obes Relat Metab Disord 24(Suppl 4):S23–S27
Rotter V, Nagaev I, Smith U (2003) Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-α, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 278:45777–45784
Paraskevas S, Huizinga JD, Loos BG (2008) A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol 35:277–290
Preshaw PM, Foster N, Taylor JJ (2007) Cross-susceptibility between periodontal disease and type 2 diabetes mellitus: an immunobiological perspective. Periodontol 2000 45:138–157
Salvi GE, Yalda B, Collins JG et al (1997) Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus populations. J Periodontol 68:127–135
Engebretson SP, Hey-Hadavi J, Ehrhardt FJ et al (2004) Gingival crevicular fluid levels of interleukin-1β and glycemic control in patients with chronic periodontitis and type 2 diabetes. J Periodontol 75:1203–1208
Salvi GE, Collins JG, Yalda B, Arnold RR, Lang NP, Offenbacher S (1997) Monocytic TNF-α secretion patterns in IDDM patients with periodontal diseases. J Clin Periodontol 24:8–16
Alba-Loureiro TC, Munhoz CD, Martins JO et al (2007) Neutrophil function and metabolism in individuals with diabetes mellitus. Braz J Med Biol Res 40:1037–1044
Alba-Loureiro TC, Hirabara SM, Mendonca JR, Curi R, Pithon-Curi TC (2006) Diabetes causes marked changes in function and metabolism of rat neutrophils. J Endocrinol 188:295–303
Manouchehr-Pour M, Spagnuolo PJ, Rodman HM, Bissada NF (1981) Impaired neutrophil chemotaxis in diabetic patients with severe periodontitis. J Dent Res 60:729–730
Graves DT, Liu R, Alikhani M, Al-Mashat H, Trackman PC (2006) Diabetes-enhanced inflammation and apoptosis—impact on periodontal pathology. J Dent Res 85:15–21
Naguib G, Al-Mashat H, Desta T, Graves DT (2004) Diabetes prolongs the inflammatory response to a bacterial stimulus through cytokine dysregulation. J Invest Dermatol 123:87–92
D’Aiuto F, Parkar M, Andreou G et al (2004) Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 83:156–160
Iwamoto Y, Nishimura F, Nakagawa M et al (2001) The effect of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes. J Periodontol 72:774–778
Marcaccini AM, Meschiari CA, Sorgi CA et al (2009) Circulating interleukin-6 and high-sensitivity C-reactive protein decrease after periodontal therapy in otherwise healthy subjects. J Periodontol 80:594–602
O’Connell PAA, Taba M, Nomizo A et al (2008) Effects of periodontal therapy on glycemic control and inflammatory markers. J Periodontol 79:774–783
Lalla E, Lamster IB, Stern DM, Schmidt AM (2001) Receptor for advanced glycation end products, inflammation, and accelerated periodontal disease in diabetes: mechanisms and insights into therapeutic modalities. Ann Periodontol 6:113–118
Vlassara H (2001) The AGE-receptor in the pathogenesis of diabetic complications. Diabetes Metab Res 17:436–443
Wong RK, Pettit AI, Quinn PA, Jennings SC, Davies JE, Ng LL (2003) Advanced glycation end products stimulate an enhanced neutrophil respiratory burst mediated through the activation of cytosolic phospholipase A2 and generation of arachidonic acid. Circulation 108:1858–1864
Santana RB, Xu L, Chase HB, Amar S, Graves DT, Trackman PC (2003) A role for advanced glycation end products in diminished bone healing in type 1 diabetes. Diabetes 52:1502–1510
Cortizo AM, Lettieri MG, Barrio DA, Mercer N, Etcheverry SB, McCarthy AD (2003) Advanced glycation end-products (AGEs) induce concerted changes in the osteoblastic expression of their receptor RAGE and in the activation of extracellular signal-regulated kinases (ERK). Mol Cell Biochem 250:1–10
Liu R, Desta T, He H, Graves DT (2004) Diabetes alters the response to bacteria by enhancing fibroblast apoptosis. Endocrinology 145:2997–3003
Thorstensson H, Dahlen G, Hugoson A (1995) Some suspected periodontopathogens and serum antibody response in adult long-duration insulin-dependent diabetics. J Clin Periodontol 22:449–458
Takahashi K, Nishimura F, Kurihara M et al (2001) Subgingival microflora and antibody responses against periodontal bacteria of young Japanese patients with type 1 diabetes mellitus. J Int Acad Periodontol 3:104–111
Goodson JM, Groppo D, Halem S, Carpino E (2009) Is obesity an oral bacterial disease? J Dent Res 88:519–523
Ley RE, Turnbaugh PJ, Klein S, Gordon JI (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444:1022–1023
Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444:1027–1031
Gubern C, Lopez-Bermejo A, Biarnes J, Vendrell J, Ricart W, Fernandez-Real JM (2006) Natural antibiotics and insulin sensitivity: the role of bactericidal/permeability-increasing protein. Diabetes 55:216–224
Vrieze A, Holleman F, Zoetendal EG, de Vos WM, Hoekstra JBL, Nieuwdorp M (2010) The environment within: how gut microbiota may influence metabolism and body composition. Diabetologia 53:606–613
Janket SJ, Wightman A, Baird AE, Van Dyke TE, Jones JA (2005) Does periodontal treatment improve glycemic control in diabetic patients? A meta-analysis of intervention studies. J Dent Res 84:1154–1159
Darre L, Vergnes JN, Gourdy P, Sixou M (2008) Efficacy of periodontal treatment on glycaemic control in diabetic patients: a meta-analysis of interventional studies. Diabetes Metab 34:497–506
Teeuw WJ, Gerdes VEA, Loos BG (2010) Effect of periodontal treatment on glycemic control of diabetic patients: a systematic review and meta-analysis. Diabetes Care 33:421–427
Simpson TC, Needleman I, Wild SH, Moles DR, Mills EJ (2010) Treatment of periodontal disease for glycaemic control in people with diabetes. Cochrane Database Syst Rev. doi: 10.1002/14651858.CD004714.pub2
Spangler L, Reid RJ, Inge R et al (2010) Cross-sectional study of periodontal care and glycosylated hemoglobin in an insured population. Diabetes Care 33:1753–1758
Jones JA, Miller DR, Wehler CJ et al (2007) Does periodontal care improve glycemic control? The Department of Veterans Affairs Dental Diabetes Study. J Clin Periodontol 34:46–52
Kiran M, Arpak N, Unsal E, Erdogan MF (2005) The effect of improved periodontal health on metabolic control in type 2 diabetes mellitus. J Clin Periodontol 32:266–272
Yun F, Firkova EI, Jun-Qi L, Xun H (2007) Effect of non-surgical periodontal therapy on patients with type 2 diabetes mellitus. Folia Medica (Plovdiv) 49:32–36
Stratton IM, Adler AI, Neil HA et al (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405–412
US Department of Health and Human Services (2000) Oral health in America: a report of the surgeon general. US Department of Health and Human Services, National Institute of Dental and Craniofacial Research, National Institutes of Health, Rockville
WHO (2007) Oral health: action plan for promotion and integrated disease prevention (EB120/10). 120th Session, 22–30 January. WHO, Geneva
Home P, Mant J, Diaz J, Turner C (2008) Guideline Development Group. Management of type 2 diabetes: summary of updated NICE guidance. BMJ 336:1306–1308
Davies MJ, Heller S, Khunti K, Skinner TC (2008) The DESMOND educational intervention. Chronic Illn 4:38–40
Deakin TA, Cade JE, Williams R, Greenwood DC (2006) Structured patient education: the diabetes X-PERT Programme makes a difference. Diabetic Med 23:944–954
Gillett M, Dallosso HM, Dixon S et al (2010) Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis. BMJ 341:c4093
Jonsson B, Ohrn K, Oscarson N, Lindberg P (2009) The effectiveness of an individually tailored oral health educational programme on oral hygiene behaviour in patients with periodontal disease: a blinded randomized-controlled clinical trial (one-year follow-up). J Clin Periodontol 36:1025–1034
Jonsson B, Ohrn K, Oscarson N, Lindberg P (2009) An individually tailored treatment programme for improved oral hygiene: introduction of a new course of action in health education for patients with periodontitis. Int J Dent Hyg 7:166–175
Syrjala AM, Kneckt MC, Knuuttila ML (1999) Dental self-efficacy as a determinant to oral health behaviour, oral hygiene and HbA1c level among diabetic patients. J Clin Periodontol 26:616–621
Kneckt MC, Syrjala AM, Knuuttila ML (2000) Attributions to dental and diabetes health outcomes. J Clin Periodontol 27:205–211
Soskolne WA, Klinger A (2001) The relationship between periodontal diseases and diabetes: an overview. Ann Periodontol 6:91–98